TY - JOUR
T1 - Short-chain fatty acids and bile acids in human faeces are associated with the intestinal cholesterol conversion status
AU - Matysik, Silke
AU - Krautbauer, Sabrina
AU - Liebisch, Gerhard
AU - Schött, Hans-Frieder
AU - Kjølbæk, Louise
AU - Astrup, Arne
AU - Blachier, Francois
AU - Beaumont, Martin
AU - Nieuwdorp, Max
AU - Hartstra, Annick
AU - Rampelli, Simone
AU - Pagotto, Uberto
AU - Iozzo, Patricia
N1 - Funding Information: This work was supported by the European Union's Seventh Framework Programme (FP7) MyNewGut (Grant Agreement 613979) and the Ziel ETZ programme (Bayerisch‐Böhmischer‐Stoffwechsel‐Verbund; European Regional Development Fund, Project 118). The authors are grateful to Julia Schneider and Sebastian Roth for their expert technical assistance. Publisher Copyright: © 2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/8
Y1 - 2021/8
N2 - Background and Purpose: The analysis of human faecal metabolites can provide an insight into metabolic interactions between gut microbiota and the host organism. The creation of metabolic profiles in faeces has received little attention until now, and reference values, especially in the context of dietary and therapeutic interventions, are missing. Exposure to xenobiotics significantly affects the physiology of the microbiome, and microbiota manipulation and short-chain fatty acid administration have been proposed as treatment targets for several diseases. The aim of the present study is to give concomitant concentration ranges of faecal sterol species, bile acids and short-chain fatty acids, based on a large cohort. Experimental Approach: Sterol species, bile acids and short-chain fatty acids in human faeces from 165 study participants were quantified by LC–MS/MS. For standardization, we refer all values to dry weight of faeces. Based on the individual intestinal sterol conversion, we classified participants into low and high converters according to their coprostanol/cholesterol ratio. Key Results: Low converters excrete more straight-chain fatty acids and bile acids than high converters; 5th and 95th percentile and median of bile acids and short-chain fatty acids were calculated for both groups. Conclusion and Implications: We give concentration ranges for 16 faecal metabolites that can serve as reference values. Patient stratification into high or low sterol converter groups is associated with significant differences in faecal metabolites with biological activities. Such stratification should then allow better assessment of faecal metabolites before therapeutic interventions. LINKED ARTICLES: This article is part of a themed issue on Oxysterols, Lifelong Health and Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.16/issuetoc.
AB - Background and Purpose: The analysis of human faecal metabolites can provide an insight into metabolic interactions between gut microbiota and the host organism. The creation of metabolic profiles in faeces has received little attention until now, and reference values, especially in the context of dietary and therapeutic interventions, are missing. Exposure to xenobiotics significantly affects the physiology of the microbiome, and microbiota manipulation and short-chain fatty acid administration have been proposed as treatment targets for several diseases. The aim of the present study is to give concomitant concentration ranges of faecal sterol species, bile acids and short-chain fatty acids, based on a large cohort. Experimental Approach: Sterol species, bile acids and short-chain fatty acids in human faeces from 165 study participants were quantified by LC–MS/MS. For standardization, we refer all values to dry weight of faeces. Based on the individual intestinal sterol conversion, we classified participants into low and high converters according to their coprostanol/cholesterol ratio. Key Results: Low converters excrete more straight-chain fatty acids and bile acids than high converters; 5th and 95th percentile and median of bile acids and short-chain fatty acids were calculated for both groups. Conclusion and Implications: We give concentration ranges for 16 faecal metabolites that can serve as reference values. Patient stratification into high or low sterol converter groups is associated with significant differences in faecal metabolites with biological activities. Such stratification should then allow better assessment of faecal metabolites before therapeutic interventions. LINKED ARTICLES: This article is part of a themed issue on Oxysterols, Lifelong Health and Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.16/issuetoc.
KW - bile acids
KW - faecal short chain fatty acids
KW - sterols
UR - http://www.scopus.com/inward/record.url?scp=85105136859&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/bph.15440
DO - https://doi.org/10.1111/bph.15440
M3 - Article
C2 - 33751575
SN - 0007-1188
VL - 178
SP - 3342
EP - 3353
JO - British journal of pharmacology
JF - British journal of pharmacology
IS - 16
ER -